logo
15:55 May 29

GlaxoSmithKline Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2210.20
-86.00 (-3.75%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

GlaxoSmithKline Pharmaceuticals Ltd. Financials

GlaxoSmithKline Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2210.20
-86.00 (-3.75%)
15:55 May 29
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

30/100
Expensive Valuation

Technical

35/100
Technically Neutral

Strength

7

Weakness

7

Opportunity

0

Threats

1

45.68 %

ROE %

23.95 %

ROA %

61.15

EPS

133.84

BVPS

27.10 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
3278.03 3251.72 3453.71 3749.21 3821.67
Operating Expenses +
2516.14 2447.44 2545.02 2571.85 2512.47
Raw Material
1340.62 1215.92 1398.25 1345.01 1346.6
Increase Decrease in Cost
15.57 68.96 -63.72 45.85 4.46
Other Manufacturing Expense
0 73.85 0 0 0
Employee Cost
610.23 594.99 624.39 579.7 607.25
Miscellaneous Expenses
2008.6 2070.58 2292.26 2291.51 2375.06
Operating Profit
761.89 804.28 908.69 1177.36 1309.2
Other Income
75.78 100.66 122.59 145.93 145.36
Depreciation
68.19 65.77 69.68 66.79 66.44
Interest
2 1.81 1.8 1.31 2.73
Profit before tax and exceptio..
767.47 837.37 959.8 1255.19 1385.39
Exceptional Items
11.58 -0.97 -143.62 4.69 20.62
PBT
779.05 836.4 816.19 1259.88 1406.01
Provision for Taxation
398.28 228.76 226.23 332.3 370.03
Net Profit
1694.72 610.69 589.96 927.58 1035.98
NET Profit after MI
1694.72 616.72 594.13 930.24 1035.98
EPS
100.04 36.05 41.14 54.76 61.15
Operating Profit Margin (%)
23.24 24.73 26.31 31.4 34.26
Net Profit Margin (%)
51.7 18.97 17.2 24.81 27.11

GlaxoSmithKline Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: